{"address1": "240 East Grand Avenue", "address2": "2nd Floor", "city": "South San Francisco", "state": "CA", "zip": "94080", "country": "United States", "phone": "650 388 5600", "website": "https://www.oricpharma.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "ORIC Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of therapies to counter the resistance mechanisms cancers in the United States. Its clinical stage product candidates include ORIC-114, a brain penetrant orally bioavailable irreversible inhibitor, currently under Phase 1b study, that selectively target epidermal growth factor receptor (EGFR) exon 20 and human epidermal growth factor receptor 2 exon 20 with high potency towards exon 20 insertion mutations; and ORIC-944, an allosteric inhibitor of the polycomb repressive complex 2 for prostate cancer, currently under Phase 1b study. The company develops ORIC-533, an orally bioavailable small molecule inhibitor of CD73; and ORIC-613, a small molecule therapeutic intended to address a mechanism of innate resistance found in a subset of breast cancers. It has clinical development collaboration agreement for a potential Phase 2 study of ORIC-533 in multiple myeloma with Pfizer Inc.; a clinical trial collaboration and supply agreement with Bayer to evaluate ORIC-944 in combination with Nubeqa AR inhibitor; and a clinical trial collaboration and supply agreement with Johnson & Johnson to evaluate ORIC 944 in combination with Erleada AR inhibitor. The company was incorporated in 2014 and is headquartered in South San Francisco, California.", "fullTimeEmployees": 115, "companyOfficers": [{"maxAge": 1, "name": "Dr. Richard A. Heyman Ph.D.", "age": 67, "title": "Co-Founder, Independent Chairman & Member of Scientific Advisory Board", "yearBorn": 1957, "fiscalYear": 2023, "totalPay": 93000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Jacob M. Chacko M.B.A., M.D.", "age": 45, "title": "President, CEO & Director", "yearBorn": 1979, "fiscalYear": 2023, "totalPay": 961003, "exercisedValue": 0, "unexercisedValue": 8457933}, {"maxAge": 1, "name": "Mr. Dominic G. Piscitelli CPA, M.B.A.", "age": 49, "title": "Chief Financial Officer", "yearBorn": 1975, "fiscalYear": 2023, "totalPay": 654742, "exercisedValue": 0, "unexercisedValue": 1012054}, {"maxAge": 1, "name": "Dr. Pratik S. Multani M.D., M.S.", "age": 57, "title": "Chief Medical Officer", "yearBorn": 1967, "fiscalYear": 2023, "totalPay": 715220, "exercisedValue": 0, "unexercisedValue": 2435303}, {"maxAge": 1, "name": "Dr. Charles L. Sawyers B.A., M.D., Ph.D.", "age": 65, "title": "Co-Founder & Member of Scientific Advisory Board", "yearBorn": 1959, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Scott W. Lowe Ph.D.", "title": "Co-Founder & Member of Scientific Advisory Board", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Lori Sickels Friedman Ph.D.", "age": 60, "title": "Chief Scientific Officer", "yearBorn": 1964, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Christian V. Kuhlen Esq., J.D., M.D.", "age": 51, "title": "General Counsel", "yearBorn": 1973, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Daniel  Iazzetti", "title": "VP & Head of People", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Edna  Chow Maneval Ph.D.", "age": 63, "title": "Executive Vice President of Clinical Development", "yearBorn": 1961, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 9, "boardRisk": 6, "compensationRisk": 9, "shareHolderRightsRisk": 8, "overallRisk": 8, "governanceEpochDate": 1743465600, "compensationAsOfEpochDate": 1703980800, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 5.58, "open": 5.49, "dayLow": 5.26, "dayHigh": 5.68, "regularMarketPreviousClose": 5.58, "regularMarketOpen": 5.49, "regularMarketDayLow": 5.26, "regularMarketDayHigh": 5.68, "payoutRatio": 0.0, "beta": 1.245, "forwardPE": -2.724138, "volume": 1257467, "regularMarketVolume": 1257467, "averageVolume": 1071978, "averageVolume10days": 1061910, "averageDailyVolume10Day": 1061910, "bid": 5.52, "ask": 5.57, "bidSize": 2, "askSize": 12, "marketCap": 392778208, "fiftyTwoWeekLow": 5.25, "fiftyTwoWeekHigh": 14.67, "fiftyDayAverage": 8.607, "twoHundredDayAverage": 9.14345, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 146175344, "profitMargins": 0.0, "floatShares": 46231360, "sharesOutstanding": 71026800, "sharesShort": 13969650, "sharesShortPriorMonth": 12039954, "sharesShortPreviousMonthDate": 1739491200, "dateShortInterest": 1741910400, "sharesPercentSharesOut": 0.1967, "heldPercentInsiders": 0.094390005, "heldPercentInstitutions": 1.03757, "shortRatio": 15.12, "shortPercentOfFloat": 0.1997, "impliedSharesOutstanding": 78295296, "bookValue": 3.423, "priceToBook": 1.6155419, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1735603200, "netIncomeToCommon": -127847000, "trailingEps": -1.83, "forwardEps": -2.03, "enterpriseToEbitda": -1.031, "52WeekChange": -0.51448643, "SandP52WeekChange": 0.08089435, "quoteType": "EQUITY", "currentPrice": 5.53, "targetHighPrice": 25.0, "targetLowPrice": 13.0, "targetMeanPrice": 19.08333, "targetMedianPrice": 20.0, "recommendationMean": 1.15385, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 12, "totalCash": 255960000, "totalCashPerShare": 3.604, "ebitda": -141788000, "totalDebt": 9357000, "quickRatio": 10.302, "currentRatio": 10.555, "debtToEquity": 3.849, "returnOnAssets": -0.33948, "returnOnEquity": -0.54728, "freeCashflow": -67100376, "operatingCashflow": -112662000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "ORIC", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "shortName": "Oric Pharmaceuticals, Inc.", "longName": "ORIC Pharmaceuticals, Inc.", "preMarketChange": 0.10449982, "preMarketChangePercent": 1.8896892, "preMarketPrice": 5.6345, "regularMarketChange": -0.049999714, "regularMarketDayRange": "5.26 - 5.68", "fullExchangeName": "NasdaqGS", "averageDailyVolume3Month": 1071978, "fiftyTwoWeekLowChange": 0.2800002, "fiftyTwoWeekLowChangePercent": 0.053333372, "fiftyTwoWeekRange": "5.25 - 14.67", "fiftyTwoWeekHighChange": -9.139999, "fiftyTwoWeekHighChangePercent": -0.6230402, "fiftyTwoWeekChangePercent": -51.448643, "earningsTimestamp": 1739912700, "earningsTimestampStart": 1746442740, "earningsTimestampEnd": 1746792000, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -1.83, "epsForward": -2.03, "epsCurrentYear": -2.00556, "priceEpsCurrentYear": -2.7573347, "fiftyDayAverageChange": -3.0770001, "fiftyDayAverageChangePercent": -0.35749972, "twoHundredDayAverageChange": -3.6134496, "twoHundredDayAverageChangePercent": -0.39519542, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "1.2 - Strong Buy", "cryptoTradeable": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1587735000000, "regularMarketChangePercent": -0.89605224, "regularMarketPrice": 5.53, "corporateActions": [], "preMarketTime": 1743595201, "regularMarketTime": 1743537601, "exchange": "NMS", "messageBoardId": "finmb_303713108", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "marketState": "PRE", "displayName": "ORIC Pharmaceuticals", "trailingPegRatio": null}